Virus-Like Particle Purification via Calcium-Deoxycholate Precipitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for separating virus-like particles from host cells are costly due to the requirement of cesium chloride density gradient centrifugation and subsequent gel filtration chromatography steps.

Innovation Solution

A method that involves adding a desorption buffer containing deoxycholic acid and/or its soluble salts to release virus-like particles, followed by precipitation with a soluble calcium salt, allowing for their separation and purification without the need for cesium chloride density gradient centrifugation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If cesium chloride density gradient centrifugation and gel filtration chromatography are used for purification, then high purity of virus-like particles is achieved, but production costs increase significantly

Engineering Contradiction:
Improvepurity of virus-like particlesVSAvoidproduction cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The invention extracts and utilizes the specific property of deoxycholic acid to selectively precipitate virus-like particles from the supernatant. By adding calcium chloride, the deoxycholic acid forms an insoluble calcium salt that precipitates together with the virus-like particles, separating them from other cellular components. This extraction-based approach replaces the need for expensive cesium chloride density gradient centrifugation and gel filtration chromatography, achieving comparable purity at lower cost.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical parameter of the system by introducing deoxycholic acid and calcium ions. The addition of calcium chloride causes deoxycholic acid to form an insoluble calcium salt, changing the solubility parameter of the system. This parameter change enables selective precipitation of virus-like particles at a specific stage of the purification process, eliminating the need for subsequent expensive purification steps while maintaining high purity.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If multiple purification steps including ultracentrifugation and chromatography are performed, then virus-like particles are highly purified, but processing time and operational complexity increase

Engineering Contradiction:
Improvepurity of virus-like particlesVSAvoidnumber of purification steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention merges the functions of multiple purification steps into a single precipitation operation. The addition of calcium chloride simultaneously achieves separation of virus-like particles from cellular debris, concentration, and purification in one step. This consolidates what would traditionally require multiple separate operations (ultracentrifugation, chromatography, etc.) into a single efficient step, reducing both operational complexity and processing time.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention introduces deoxycholic acid as an intermediary substance that mediates the separation process. The deoxycholic acid acts as a bridge between the virus-like particles and the precipitating agent (calcium chloride). It selectively binds to the virus-like particles and forms an insoluble calcium salt, enabling their specific precipitation and separation from the supernatant without requiring complex equipment or multiple processing steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves comparable purity to traditional methods while eliminating the expensive steps of cesium chloride density gradient centrifugation and gel filtration chromatography, reducing overall costs.

Implementation Method 1

e) the virus-like particles are desorbed from the separated-off adsorbent, so that they pass into a supernatant of a second suspension formed thereby

Methodology Applied
Scientific EffectDesorption: Desorption

Implementation Method 2

c) an adsorbent is added to the supernatant separated from the first suspension such that the virus-like particles are adsorbed by the adsorbent

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 3

g) a soluble calcium salt is added to the separated-off supernatant, forming a precipitate containing a calcium salt of the deoxycholic acid and the virus-like particles

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS11053478B2Method for separating virus-like particles from a cell suspension
Publication Date: 2021.07.06 ARTES BIOTECHNOLOGIE GMBH
  • US11053478B2 patent drawing
  • US11053478B2 patent drawing

AI summary

A method for separating virus-like particles from a cell suspension of host cells. The virus-like particles having at least one envelope protein embedded in a lipid double membrane including at least a portion corresponding to a small envelope protein of a virus of the family Hepadnaviridae. The host cells are disrupted to obtain a first suspension. A supernatant containing the virus-like particles is separated from the first suspension. Then, an adsorbent is added to the supernatant and separated off. Then, the virus-like particles are desorbed from the adsorbent by adding a desorption buffer. A soluble calcium salt is added to a supernatant separated from the second suspension to form a precipitate, the precipitate formed is separated off and transferred to a third suspension. The virus-like particles are separated from the third suspension and purified.